
Home » Dr. Reddy’s Announces the Launch of Amlodipine Besylate and Benazepril Hydrochloride Capsules
Dr. Reddy’s Announces the Launch of Amlodipine Besylate and Benazepril Hydrochloride Capsules
July 7, 2011
Dr. Reddy’s announced it has launched Amlodipine Besylate and Benazepril Hydrochloride capsules, 5 mg/40 mg and 10 mg/40 mg, a bioequivalent generic version of Lotrel capsules, in the U.S. market following the approval by the FDA of Dr. Reddy’s ANDA for amlodipine besylate and benazepril hydrochloride capsules.
MarketWatch
MarketWatch
Upcoming Events
-
10Mar
-
16Mar
-
18Mar
-
23Mar
-
30Mar
-
06Apr